135.37
price up icon1.39%   1.85
after-market アフターアワーズ: 135.37
loading
前日終値:
$133.52
開ける:
$132.36
24時間の取引高:
807.82K
Relative Volume:
1.07
時価総額:
$7.95B
収益:
$551.35M
当期純損益:
$-189.33M
株価収益率:
-41.13
EPS:
-3.2916
ネットキャッシュフロー:
$-35.09M
1週間 パフォーマンス:
-0.35%
1か月 パフォーマンス:
+16.30%
6か月 パフォーマンス:
+50.60%
1年 パフォーマンス:
+50.48%
1日の値動き範囲:
Value
$130.64
$136.26
1週間の範囲:
Value
$130.04
$137.87
52週間の値動き範囲:
Value
$73.16
$146.75

Glaukos Corp Stock (GKOS) Company Profile

Name
名前
Glaukos Corp
Name
セクター
Healthcare (1110)
Name
電話
949-367-9600
Name
住所
1 GLAUKOS WAY, ALISO VIEJO, CA
Name
職員
1,094
Name
Twitter
@GlaukosCorp
Name
次回の収益日
2026-04-29
Name
最新のSEC提出書
Name
GKOS's Discussions on Twitter

Compare GKOS vs ABT, SYK, MDT, BSX, EW

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
GKOS icon
GKOS
Glaukos Corp
135.37 7.84B 551.35M -189.33M -35.09M -3.2916
ABT icon
ABT
Abbott Laboratories
82.56 146.87B 45.13B 6.28B 7.38B 3.5895
SYK icon
SYK
Stryker Corp
282.58 109.33B 25.27B 3.34B 4.57B 8.6358
MDT icon
MDT
Medtronic Plc
74.54 97.77B 35.48B 4.64B 5.41B 3.582
BSX icon
BSX
Boston Scientific Corp
53.37 80.16B 20.62B 3.56B 3.48B 2.3847
EW icon
EW
Edwards Lifesciences Corp
77.17 46.04B 6.30B 1.07B 1.09B 1.8406

Glaukos Corp Stock (GKOS) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2025-10-27 アップグレード Wells Fargo Equal Weight → Overweight
2025-10-01 開始されました Goldman Buy
2025-05-01 ダウングレード Wells Fargo Overweight → Equal Weight
2025-02-19 アップグレード Mizuho Neutral → Outperform
2024-12-11 アップグレード Citigroup Neutral → Buy
2024-12-06 開始されました UBS Buy
2024-12-02 ダウングレード Morgan Stanley Equal-Weight → Underweight
2024-07-10 ダウングレード Citigroup Buy → Neutral
2024-05-06 アップグレード Jefferies Hold → Buy
2023-12-21 アップグレード JP Morgan Neutral → Overweight
2023-12-04 開始されました Morgan Stanley Equal-Weight
2023-11-28 開始されました Truist Buy
2023-11-08 アップグレード Wells Fargo Equal Weight → Overweight
2023-06-07 アップグレード Piper Sandler Neutral → Overweight
2022-12-22 開始されました Mizuho Neutral
2022-12-19 アップグレード JP Morgan Underweight → Neutral
2022-12-12 アップグレード Citigroup Neutral → Buy
2022-10-14 再開されました Stephens Overweight
2022-10-04 開始されました Needham Buy
2022-07-12 アップグレード Stifel Hold → Buy
2022-02-03 アップグレード William Blair Mkt Perform → Outperform
2022-01-19 アップグレード Wells Fargo Underweight → Equal Weight
2022-01-18 アップグレード BTIG Research Neutral → Buy
2021-11-03 アップグレード Stephens Equal-Weight → Overweight
2021-07-26 ダウングレード Stephens Overweight → Equal-Weight
2021-07-20 ダウングレード Wells Fargo Equal Weight → Underweight
2021-07-14 ダウングレード Oppenheimer Outperform → Perform
2021-07-14 ダウングレード William Blair Outperform → Mkt Perform
2021-04-08 アップグレード Oppenheimer Perform → Outperform
2021-01-29 ダウングレード Piper Sandler Overweight → Neutral
2020-12-16 アップグレード Citigroup Sell → Neutral
2020-12-09 開始されました Oppenheimer Perform
2020-11-17 アップグレード Wells Fargo Underweight → Equal Weight
2020-10-08 ダウングレード JP Morgan Neutral → Underweight
2020-06-15 開始されました Jefferies Hold
2020-03-05 開始されました Citigroup Sell
2020-02-28 ダウングレード JP Morgan Overweight → Neutral
2020-01-06 アップグレード Berenberg Hold → Buy
2019-12-12 ダウングレード Wells Fargo Outperform → Underperform
2019-09-30 ダウングレード BofA/Merrill Buy → Underperform
2019-03-08 開始されました BTIG Research Neutral
2018-08-30 開始されました Berenberg Hold
2018-08-29 アップグレード JP Morgan Neutral → Overweight
2018-08-03 繰り返されました Stifel Hold
2018-06-21 ダウングレード JP Morgan Overweight → Neutral
2018-04-13 ダウングレード Stifel Buy → Hold
2018-03-01 繰り返されました Cantor Fitzgerald Buy
2017-03-02 繰り返されました Cantor Fitzgerald Overweight
2017-01-06 アップグレード Stifel Hold → Buy
2016-10-27 開始されました Wells Fargo Outperform
すべてを表示

Glaukos Corp (GKOS) 最新ニュース

pulisher
May 11, 2026

[144] GLAUKOS Corp SEC Filing - Stock Titan

May 11, 2026
pulisher
May 11, 2026

Presbyopia Market to Witness Accelerated Growth at a CAGR of 4.9% During the Forecast Period (2026–2036) Supported by Expanding Treatment Landscape | DelveInsight - GlobeNewswire Inc.

May 11, 2026
pulisher
May 09, 2026

Number of shareholders of Glaukos Corp – LS:A14VCK - TradingView

May 09, 2026
pulisher
May 08, 2026

Glaukos Corp stock (US3773221029): Raised 2026 sales guidance lifts medtech profile - AD HOC NEWS

May 08, 2026
pulisher
May 08, 2026

Glaukos wins permanent J-code for Epioxa keratoconus therapy - MSN

May 08, 2026
pulisher
May 06, 2026

Glaukos Corp. Hits New 52-Week High at $145.50, Reflecting Strong Growth - Markets Mojo

May 06, 2026
pulisher
May 04, 2026

Glaukos SVP & CFO Alex Thurman sells $1.4m in shares By Investing.com - Investing.com South Africa

May 04, 2026
pulisher
May 04, 2026

Glaukos SVP & CFO Alex Thurman sells $1.4m in shares - Investing.com Nigeria

May 04, 2026
pulisher
May 04, 2026

Glaukos president & COO Gilliam sells $2.8m in company stock - Investing.com Australia

May 04, 2026
pulisher
May 04, 2026

Glaukos president & COO Gilliam sells $2.8m in company stock By Investing.com - Investing.com South Africa

May 04, 2026
pulisher
May 04, 2026

Glaukos (GKOS) CFO exercises options and sells 10,000 shares under plan - Stock Titan

May 04, 2026
pulisher
May 04, 2026

GLAUKOS (GKOS) President & COO sells 19,573 shares in open-market trade - Stock Titan

May 04, 2026
pulisher
May 04, 2026

GLAUKOS (GKOS) director Leana Wen sells 1,700 shares, holds 19,739 - Stock Titan

May 04, 2026
pulisher
May 04, 2026

Glaukos Corp Leads Innovation in Chronic Eye Disease Treatment with iDose TR and Epioxa Therapies – 2026 Investor Update - Minichart

May 04, 2026
pulisher
May 04, 2026

Glaukos to present May 2026 investor slide deck highlighting iDose TR, Epioxa launch and 2026 guidance - TradingView

May 04, 2026
pulisher
May 04, 2026

[8-K] GLAUKOS Corp Reports Material Event - Stock Titan

May 04, 2026
pulisher
May 03, 2026

How The Glaukos (GKOS) Narrative Is Shifting With New Guidance And Product Ramp Expectations - Yahoo Finance

May 03, 2026
pulisher
May 03, 2026

UBS Group AG Increases Position in Glaukos Corporation $GKOS - MarketBeat

May 03, 2026
pulisher
May 02, 2026

MSN - MSN

May 02, 2026
pulisher
May 02, 2026

Earnings Update: Here's Why Analysts Just Lifted Their Glaukos Corporation (NYSE:GKOS) Price Target To US$148 - Sahm

May 02, 2026
pulisher
May 02, 2026

Glaukos (NYSE:GKOS) Stock Rating Upgraded by Wall Street Zen - MarketBeat

May 02, 2026
pulisher
May 01, 2026

Glaukos Corp. Earnings Call Signals Growth Momentum - The Globe and Mail

May 01, 2026
pulisher
May 01, 2026

Glaukos Up Over 19%, On Track for Largest Percent Increase Since December 2023 -- Data Talk - Moomoo

May 01, 2026
pulisher
May 01, 2026

Fidelity Brokerage Services LLC (GKOS) files Form 144 to sell 19,573 shares - Stock Titan

May 01, 2026
pulisher
May 01, 2026

GKOS SWOT Analysis: Key Insights from the 10-Q Filing - GuruFocus

May 01, 2026
pulisher
Apr 30, 2026

MSN Money - MSN

Apr 30, 2026
pulisher
Apr 30, 2026

GKOS Maintains Overweight Rating by JP Morgan -- Price Target Ra - GuruFocus

Apr 30, 2026
pulisher
Apr 30, 2026

GKOS Maintained by Citigroup -- Price Target Raised to $140 - GuruFocus

Apr 30, 2026
pulisher
Apr 30, 2026

JPMorgan Chase & Co. Forecasts Strong Price Appreciation for Glaukos (NYSE:GKOS) Stock - MarketBeat

Apr 30, 2026
pulisher
Apr 30, 2026

Glaukos (GKOS) Jumps As Earnings Beat Fuels Bullish Outlook - StocksToTrade

Apr 30, 2026
pulisher
Apr 30, 2026

Glaukos stock reaches 52-week high at $143.81 By Investing.com - Investing.com Canada

Apr 30, 2026
pulisher
Apr 30, 2026

GKOS Maintained by Wells Fargo -- Price Target Raised to $138.00 - GuruFocus

Apr 30, 2026
pulisher
Apr 30, 2026

Midday Stock Roundup: Alignment Healthcare Shares Fall 12% Following Q1 Earnings - Orange County Business Journal

Apr 30, 2026
pulisher
Apr 30, 2026

Glaukos Gains on Q1 Earnings Beat & Improved 2026 Revenue Outlook - Zacks Investment Research

Apr 30, 2026
pulisher
Apr 30, 2026

Glaukos Stock Surges 18% on Record Q1 Sales Beat and Raised 2026 Outlook as iDose TR Demand Soars - International Business Times Australia

Apr 30, 2026
pulisher
Apr 30, 2026

GKOS Maintained by BTIG -- Price Target Raised to $141.00 - GuruFocus

Apr 30, 2026
pulisher
Apr 30, 2026

GKOS Maintained by Needham -- Price Target Raised to $136 - GuruFocus

Apr 30, 2026
pulisher
Apr 30, 2026

Glaukos (GKOS) Rule 144: Fidelity lists 10,000‑share resale, insider trades - Stock Titan

Apr 30, 2026
pulisher
Apr 30, 2026

Glaukos (NYSE:GKOS) Sets New 1-Year High After Earnings Beat - MarketBeat

Apr 30, 2026
pulisher
Apr 30, 2026

Glaukos stock reaches 52-week high at $143.81 - Investing.com

Apr 30, 2026
pulisher
Apr 30, 2026

Wells Fargo & Company Raises Glaukos (NYSE:GKOS) Price Target to $138.00 - MarketBeat

Apr 30, 2026
pulisher
Apr 30, 2026

Glaukos Corporation (NYSE:GKOS) Q1 2026 Earnings Call Transcript - Insider Monkey

Apr 30, 2026
pulisher
Apr 30, 2026

Glaukos (NYSE:GKOS) Stock Price Expected to Rise, BTIG Research Analyst Says - MarketBeat

Apr 30, 2026
pulisher
Apr 30, 2026

Needham & Company LLC Forecasts Strong Price Appreciation for Glaukos (NYSE:GKOS) Stock - MarketBeat

Apr 30, 2026
pulisher
Apr 30, 2026

Needham raises Glaukos stock price target to $136 on revenue beat By Investing.com - Investing.com South Africa

Apr 30, 2026
pulisher
Apr 30, 2026

Needham raises Glaukos stock price target to $136 on revenue beat - Investing.com Australia

Apr 30, 2026
pulisher
Apr 30, 2026

GLAUKOS Corp 1Q 2026: Revenue $150.6M, EPS $(0.34) — 10-Q Summary - TradingView

Apr 30, 2026
pulisher
Apr 30, 2026

BTIG raises Glaukos stock price target to $141 on strong results - Investing.com

Apr 30, 2026

Glaukos Corp (GKOS) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
ZBH ZBH
$79.58
price down icon 3.34%
STE STE
$201.85
price down icon 2.70%
$59.33
price down icon 2.11%
PHG PHG
$26.73
price down icon 1.76%
$61.70
price down icon 2.79%
EW EW
$77.17
price down icon 3.49%
大文字化:     |  ボリューム (24 時間):